Apalutamide decreased risk of death in mCSPC by 23% and 26% compared with enzalutamide and abiraterone acetate, respectively.

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the prioritization of quality of life.

Panelists discuss how cardiovascular toxicity remains a significant concern with certain tyrosine kinase inhibitors (TKIs) used in chronic myeloid leukemia (CML) treatment, particularly with the older ...

Panelists discuss how eliminating the strict mealtime restrictions with the new nilotinib formulation addresses a significant unmet need in chronic myeloid leukemia (CML) treatment by reducing ...

The MindCap mobile app is likely feasible as an assessment for cognitive function of cancer survivors, although further data ...

The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable ...

Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing ...

Providing education about patients’ diseases was difficult, according to 32% of registered nurses and 29% of infusion nurses.

The intersection of cardiology and oncology is greater than nurses and providers may assume, explained 2 experts.

Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

Social determinants of health like transportation and financial increased the occurrence of psychoneurological symptoms in ...